Skip to content
healthcare.dev

Elimitone

NDC 44911-0490, Bellis Perennis, Echinacea (Angustifolia), Trifolium Pratense, Phytolacca Decandra, Arnica Montana, Anas Barbariae, Hepatis et Cordis Extractum, Calcarea Iodata, Kali Muriaticum, Nitricum Acidum, Phosphoricum Acidum, Sulphur Iodatum, liquid, from Energique, Inc..

Product NDC
44911-0490
Status
Listed
Labeler
Energique, Inc.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0490 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BELLIS PERENNIS WHOLE3 [hp_X]/mL
  • ECHINACEA ANGUSTIFOLIA WHOLE3 [hp_X]/mL
  • TRIFOLIUM PRATENSE FLOWER3 [hp_X]/mL
  • PHYTOLACCA AMERICANA ROOT4 [hp_X]/mL
  • ARNICA MONTANA WHOLE12 [hp_X]/mL
  • CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE12 [hp_X]/mL
  • CALCIUM IODIDE12 [hp_X]/mL
  • POTASSIUM CHLORIDE12 [hp_X]/mL
  • NITRIC ACID12 [hp_X]/mL
  • PHOSPHORIC ACID12 [hp_X]/mL
  • SULFUR IODIDE12 [hp_X]/mL

Pharmacologic classes

Blood Coagulation Factor [EPC]; Calcium [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Salt [EPC]

Package NDCNDC-11Package
44911-0490-14491104900130 mL in 1 BOTTLE, DROPPER (44911-0490-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 44911-0490 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0490 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 44911-0490. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.